Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Oteseconazole by Mycovia Pharmaceuticals for Cryptococcal Meningitis: Likelihood of Approval
Oteseconazole is under clinical development by Mycovia Pharmaceuticals and currently in Phase I for Cryptococcal Meningitis. According to GlobalData, Phase...